Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
There are no records.

Web Desc
HIV Vaccines joint with Functional Cures and the Eradication of HIV Organizer(s): Nicole A. Doria-Rose, Thumbi Ndung'u and Gunilla Karlsson Hedestam Date: March 24 - 28, 2019 Location: Fairmont Chateau Whistler, Whistler, BC, Canada Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation Summary of Meeting: Despite dramatic progress in prevention and treatment of HIV, the pandemic continues, and two million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines conference presents the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. The program also includes a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders and clinical researchers on the front lines. Global Health Travel Award Deadline: October 23 2018 Scholarship Deadline: December 5 2018 Discounted Abstract Deadline: December 5 2018 Abstract Deadline: December 18 2018 Discounted Registration Deadline: January 24 2019 Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: GlaxoSmithKline Janssen Vaccines & Prevention BV We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID) Grant No. 1R13AI143345-01 Funding for this conference was made possible (in part) by 1R13AI143345-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

HIV Vaccines

joint with Functional Cures and the Eradication of HIV

Organizer(s): Nicole A. Doria-Rose, Thumbi Ndung'u and Gunilla Karlsson Hedestam

Date: March 24 - 28, 2019
Location: Fairmont Chateau Whistler, Whistler, BC, Canada

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Summary of Meeting:

Despite dramatic progress in prevention and treatment of HIV, the pandemic continues, and two million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines conference presents the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. The program also includes a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders and clinical researchers on the front lines.

Global Health Travel Award Deadline: October 23 2018

Scholarship Deadline: December 5 2018

Discounted Abstract Deadline: December 5 2018

Abstract Deadline: December 18 2018

Discounted Registration Deadline: January 24 2019

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

GlaxoSmithKline

Janssen Vaccines & Prevention BV

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI143345-01
Funding for this conference was made possible (in part) by 1R13AI143345-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Sunday, March 24 \| 4:00PM - 8:00PM Arrival and Registration Room: Macdonald Foyer
Sunday, March 24 \| 6:00PM - 8:00PM Welcome Mixer Room: Macdonald Foyer No registration fees are used to fund alcohol served at this function.
Monday, March 25 \| 7:00AM - 8:00AM Breakfast Room: Frontenac/Empress
Monday, March 25 \| 8:00AM - 9:15AM Welcome and Keynote Session (Joint) Room: Macdonald ABCD Speaker 1 of 4 * Ann J. Hessell, Oregon Health & Science University, USA
Monday, March 25 \| 8:00AM - 9:15AM Welcome and Keynote Session (Joint) Room: Macdonald ABCD Speaker 2 of 4 * Sharon R. Lewin, University of Melbourne, Australia
Monday, March 25 \| 8:00AM - 9:15AM Welcome and Keynote Session (Joint) Room: Macdonald ABCD Speaker 3 of 4 John R. Mascola, NIAID, National Institutes of Health, USA Challenges and Opportunities for Antibody-Based HIV Vaccines
Monday, March 25 \| 8:00AM - 9:15AM Welcome and Keynote Session (Joint) Room: Macdonald ABCD Speaker 4 of 4 Robert F. Siliciano, Johns Hopkins University School of Medicine, USA Understanding Barriers to HIV Cure
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 1 of 7 * Sharon R. Lewin, University of Melbourne, Australia
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 2 of 7 * Ann J. Hessell, Oregon Health & Science University, USA
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 3 of 7 David D. Ho, Aaron Diamond AIDS Research Center (ADARC), Columbia University Medical Center, USA Engineering Bispecific Antibodies to Prevent/Treat HIV Infection, Quantify Fc-Mediated Effector Functions, Measure Avidity Contribution to Virus Neutralization, and Infer HIV Envelope Spike Density
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Coffee Break
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 5 of 7 Florian Klein, University of Cologne, Germany Broadly Neutralizing Antibodies for HIV-1 Immunotherapy
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 6 of 7 Ann Marie Carias, Northwestern University, USA Short Talk: Distribution and Localization of I.V. injected VRC01 and VRC01-LS in the in vivo Rhesus Macaque Model
Monday, March 25 \| 9:15AM - 11:15AM Antibodies for Prevention, Treatment and Cure (Joint) Room: Macdonald ABCD Speaker 7 of 7 Sai Priya Anand, McGill University, Canada Short Talk: Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells
Monday, March 25 \| 11:15AM - 5:00PM On Own for Lunch
Monday, March 25 \| 11:15AM - 1:00PM Poster Setup Room: Frontenac/Empress
Monday, March 25 \| 1:00PM - 10:00PM Poster Viewing Room: Frontenac/Empress
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 1 of 9 * Willy Bogers, Biomedical Primate Research Centre, Netherlands
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 2 of 9 * Yuxing Li, University of Maryland, USA
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 3 of 9 Bridget Fisher, Seattle Children's Research Institute, USA Oral Immunization with Native-Like HIV-1 Trimers Elicits Systemic Immune Responses and Cross-Clade Reactive Anti-V1V2 Antibodies
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 4 of 9 Miroslaw K. Gorny, New York University School of Medicine, USA Tight Control of SHIV Challenge in Macaques with Vaccine-Induced Neutralizing and Non-Neutralizing Anti-V2 Antibodies
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 5 of 9 Paolo Lusso, NIAID, National Institutes of Health, USA Induction of Cross-Clade Heterologous Tier-2 HIV-1 Neutralizing Antibodies by an mRNA-Based Vaccine in Macaques
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 6 of 9 Ma Luo, University of Manitoba, Canada A Vaccine Targeting HIV Maturation Protects Cynomolgus Monkeys Against Vaginal SIVmac251 Acquisition
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 7 of 9 Mauricio A. Martins, University of Miami, USA Anti-CTLA-4 Therapy Enhances Vaccine Immunogenicity but not Efficacy Against Simian Immunodeficiency Virus Challenge in Rhesus Macaques
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 8 of 9 Kimberly M. Cirelli, La Jolla Institute for Immunology, USA Slow Delivery Immunization Enhances Germinal Center and Neutralizing Antibody Responses via Modulation of Immunodominance
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Lessons from Non-Human Primate Studies Room: Macdonald AB Speaker 9 of 9 Mario Roederer, NIAID, National Institutes of Health, USA SIV Escapes from Non-neutralizing Antibodies Blocking a4ß7 Integrin Binding
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 1 of 10 * Leor S. Weinberger, University of California, San Francisco, USA
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 2 of 10 * Rasmi Thomas, U.S. Military HIV Research Program, USA
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 3 of 10 James Arthos, NIAID, National Institutes of Health, USA A Role for MAdCAM and Retinoic Acid in Establishing Viral Replication in Gut-Associated Lymphoid Tissues
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 4 of 10 Evan Rossignol, Ragon Institute of MGH, MIT, and Harvard, USA Development of Monoclonal Antibodies from Elite Controllers to Target the HIV Reservoir
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 5 of 10 Anjie Zhen, University of California, Los Angeles, USA Checkpoint Inhibitor Dendritic Cell Vaccine Suppresses HIV-1 Replication
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 6 of 10 David F. G. Malone, University of Oxford, UK CD56neg NK Cells Have Increased Functional Response to CD16 Stimulation in Chronic HIV
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 7 of 10 Riddhima Banga, Centre Hospitalier Universitaire Vaudois, Switzerland PD-1/PD-L1 Interaction Modulates HIV-1 Transcription in Lymph Nodes of Treated Aviremic Individuals
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 8 of 10 Namita Satija, Icahn School of Medicine at Mount Sinai, USA A Genetically Encoded Switch to Monitor HIV Infection and Latency within Humanized Mice Reveals HIV-Susceptibility Associated with Diverse T Cell Transcriptional States
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 9 of 10 Carly G K Ziegler, Massachusetts Institute of Technology, USA Paired Host-Virus Single Cell Genomics Identifies Cell Types Harboring Virus in Humans and Non-Human Primates
Monday, March 25 \| 2:30PM - 4:30PM Workshop 1: Immunology of HIV Cure This session is from HIV Cures Room: Macdonald CD Speaker 10 of 10 Alexander O. Pasternak, University of Amsterdam, Netherlands CD32+CD4+ T Cells Are Highly Enriched in HIV DNA
Monday, March 25 \| 4:30PM - 5:00PM Coffee Available Room: Macdonald Foyer
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 1 of 7 * Punnee Pitisuttithum, Mahidol University, Thailand
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 2 of 7 * Susan W. Barnett, Bill & Melinda Gates Foundation, USA
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 3 of 7 Fatima Laher, University of the Witwatersrand, South Africa ALVAC-gp120 for Clade C in South Africa
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 4 of 7 Shelly Krebs, Walter Reed Army Institute of Research, USA Short Talk: B Cell Priming from RV144 Vaccination Impacts Post-Infection Antibody Responses
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 5 of 7 Lawrence Corey, Fred Hutchinson Cancer Research Center, USA Validating Neutralization as a Mechanistic Surrogate of Protection in Passive Antibody Studies
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 6 of 7 Beatrice Ondondo, Cardiff Metropolitan University, UK T-Cell Vaccine Trials for HIV
Monday, March 25 \| 5:00PM - 7:00PM Clinical Trials for Prevention: Vaccines and Antibodies Room: Macdonald AB Speaker 7 of 7 R. Keith Reeves, Harvard Medical School, USA Short Talk: Human Memory NK Cells Are Potently Induced by HIV and HIV Vaccines
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 1 of 8 * Rebecca M. Lynch, George Washington University, USA
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 2 of 8 * Brian Moldt, Gilead Sciences, USA
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 3 of 8 Galit Alter, MIT and Harvard University, USA Defining Conserved Correlates of Humoral Immune Protection Against SIV/SHIV
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 4 of 8 Michel C. Nussenzweig, HHMI/Rockefeller University, USA Targeting B Lymphocytes to Control HIV-1
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 5 of 8 Mario Roederer, NIAID, National Institutes of Health, USA Short Talk: SIV Escapes from Non-neutralizing Antibodies Blocking a4ß7 Integrin Binding
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 6 of 8 Jérémy Dufloo, Institut Pasteur, France Short Talk: Complement Activation at the Surface of HIV-1-Infected Cells
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 7 of 8 Mariya B. Shapiro, Oregon Health & Science University, USA Short Talk: Defining the Window of Opportunity for SHIV Clearance with bNAbs in Infant Macaques
Monday, March 25 \| 5:00PM - 7:00PM Development of the Innate Cell and Antibody Responses to HIV This session is from HIV Cures Room: Macdonald CD Speaker 8 of 8 Lynn Morris, National Institute for Communicable Diseases, South Africa Genetic and Structural Features of HIV-1 V2-Specific Antibodies that Mediate ADCC and Block a4ß7 Interactions
Monday, March 25 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Frontenac/Empress No registration fees are used to fund alcohol served at this function.
Monday, March 25 \| 7:30PM - 10:00PM Poster Session 1 Room: Frontenac/Empress
Tuesday, March 26 \| 7:00AM - 8:00AM Breakfast Room: Frontenac/Empress
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 1 of 10 * Ivelin Georgiev, Vanderbilt Vaccine Center, USA
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 2 of 10 * Andrew B. Ward, The Scripps Research Institute, USA
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 3 of 10 Gunilla B. Karlsson Hedestam, Karolinska Institutet, Sweden Antibody Germline Genes and Impact on Vaccine Responses
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 4 of 10 Steven E. Bosinger, Emory University, USA In vivo Lineage Tracing of Antigen-Specific B Cells after Vaccination
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 5 of 10 Ian Setliff, Vanderbilt Vaccine Center, USA Short Talk: High-Throughput Mapping of B-Cell Receptor Sequence to Antigen Specificity
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Coffee Break
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 7 of 10 James E. Voss, The Scripps Research Institute, USA Short Talk: Reprogramming the Antigen Specificity of B Cells Using Genome-Editing Technologies
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 8 of 10 Adrian B. McDermott, National Institutes of Health, USA Characterization of Antigen-Specific Memory B Cells Following Vaccination
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 9 of 10 Colin Havenar-Daughton, Vir Biotechnology, USA The Antigen-Specific Human Naive B Cell Repertoire: A Starting Point for Vaccine Responses
Tuesday, March 26 \| 8:00AM - 11:15AM New Technologies for Studying and Inducing B Cells Room: Macdonald AB Speaker 10 of 10 Kristin L. Boswell, NIAID, National Institutes of Health, USA Short Talk: Bcl-6/Bcl-xL B Cell Immortalization for Antibody Discovery in Vaccination and Chronic Infection
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 1 of 10 * Ya-Chi Ho, Yale School of Medicine, USA
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 2 of 10 * Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 3 of 10 Saba Valadkhan, Case Western Reserve University, USA An HIV-Induced Mechanism for T Cell Quiescence and Proviral Latency
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 4 of 10 Eric M. Verdin, Buck Institute for Research on Aging, USA CRISPR-Based Characterizing of Latency-Associated Pathways
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Coffee Break
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 6 of 10 Jonathan Karn, Case Western Reserve University, USA Signaling Pathways Controlling HIV Reactivation from Latency
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 7 of 10 Ivan D'Orso, University of Texas Southwestern Medical Center, USA Transcriptional Regulatory Mechanisms Shaping HIV Proviral Fate
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 8 of 10 Joe D. Hiatt, University of California, San Francisco, USA Short Talk: A Functional Map of HIV-Host Interactions in Primary Human CD4+ T cells
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 9 of 10 Peter D. Sun, NIAID, National Institutes of Health, USA Short Talk: Target HIV Viral Release Pathway as A New Antiviral Strategy
Tuesday, March 26 \| 8:00AM - 11:15AM Mechanisms of Viral Expression and Control of Host Cell Func tion This session is from HIV Cures Room: Macdonald CD Speaker 10 of 10 Richard E. Sutton, Yale University School of Medicine, USA Short Talk: Whole Exome Sequencing Identifies SNVs and Indels Associated with HIV+ Elite and Viremic Control
Tuesday, March 26 \| 11:15AM - 5:00PM On Own for Lunch
Tuesday, March 26 \| 11:15AM - 1:00PM Poster Setup Room: Frontenac/Empress
Tuesday, March 26 \| 11:30AM - 1:00PM Hands-On Computer Workshop on Los Alamos HIV Sequences Database Room: Macdonald EF Bring your own laptop if you have one Click here for more information
Tuesday, March 26 \| 1:00PM - 10:00PM Poster Viewing Room: Frontenac/Empress
Tuesday, March 26 \| 4:30PM - 5:00PM Coffee Available Room: Macdonald Foyer
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 1 of 6 * Daniela Fera, Swarthmore College, USA
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 2 of 6 Nicole A. Doria-Rose, NIAID, National Institutes of Health, USA Broadly Neutralizing Antibodies: Lessons from Natural Infection
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 3 of 6 Kevin O. Saunders, Duke University, USA Short Talk: CH505 Transmitted/Founder Envelope Elicits Tier 2 Neutralizing Antibodies Against the CD4 Binding and V1V2-Glycan Sites during Human Infection and Macaque Vaccination
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 4 of 6 Mattia Bonsignori, Duke University, USA Inference of the VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 5 of 6 Elise Landais, International AIDS Vaccine Initiative, USA Fast and Focused Maturation of a VRC01-Class Broadly Neutralizing Antibody Lineage
Tuesday, March 26 \| 5:00PM - 7:00PM Antibody-Virus Coevolution: Vaccines and Lessons from Infect ion Room: Macdonald AB Speaker 6 of 6 Marit van Gils, Amsterdam UMC, Netherlands Short Talk: Comparison of Monoclonal Antibodies Induced by BG505 SOSIP Trimer Immunization and BG505 SHIV Infection in Non-Human Primates
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 1 of 7 * George B. Kyei, University of Ghana, Ghana
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 2 of 7 * Sharon R. Lewin, University of Melbourne, Australia
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 3 of 7 Melanie M. Ott, Gladstone Institutes, USA Epigenetic Regulation of HIV Transcription
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 4 of 7 Monsef Benkirane, Institut de Genetique Humaine, France HIV-Host Interactions at the Genomic Level
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 5 of 7 Leor S. Weinberger, University of California, San Francisco, USA Discovery and Characterization of a Virus-Intrinsic HIV Latency Circuit
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 6 of 7 Luis M. Agosto, Boston Medical Center, USA Short Talk: Identification of Novel Pathways that Regulate HIV Transcription using an Unbiased Functional Screen
Tuesday, March 26 \| 5:00PM - 7:00PM Mechanism and Modulation of Latency This session is from HIV Cures Room: Macdonald CD Speaker 7 of 7 Leah Plasek, Case Western Reserve University, USA Short Talk: Investigation of Potential Roles for lncRNAs in Establishment and Maintenance of HIV Latency
Tuesday, March 26 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Frontenac/Empress No registration fees are used to fund alcohol served at this function.
Tuesday, March 26 \| 7:30PM - 10:00PM Poster Session 2 Room: Frontenac/Empress
Wednesday, March 27 \| 7:00AM - 8:00AM Breakfast Room: Frontenac/Empress
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 1 of 8 * Douglas F. Nixon, Weill Cornell Medicine, USA
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 2 of 8 * Tomas Hanke, University of Oxford, UK
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 3 of 8 Jintanat Ananworanich, US Military HIV Research Program, USA AD26 & MVA Vaccines in Acutely Treated HIV: Safety, Immunogenicity and Viral Rebound
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 4 of 8 Beatriz Mothe, IrsiCaixa AIDS Research Institute-HIVACAT, Spain Therapeutic Vaccines after Early ART: Impact on Reservoir
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Coffee Break
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 6 of 8 Warner Craig Greene, Gladstone Institute of Virology and Immunology, USA Attacking the Latent Reservoir with Convertible CAR-T Cells Programmed with HIV bNAbs
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 7 of 8 Eric Arts, Western University, Canada Combining a TLR7 Agonist with a Heterologous Virus-Like Particle for Potent and Specific Latency Reversal in Patient Samples during Stable cART
Wednesday, March 27 \| 8:00AM - 11:00AM Therapeutic Vaccines and Cure Strategies (Joint) Room: Macdonald ABCD Speaker 8 of 8 Daniel Muli Muema, Africa Health Research Institute, South Africa HIV Infection/FRESH
Wednesday, March 27 \| 11:15AM - 5:00PM On Own for Lunch
Wednesday, March 27 \| 11:15AM - 1:00PM Poster Setup Room: Frontenac/Empress
Wednesday, March 27 \| 11:30AM - 1:00PM Hands-On Computer Workshop on Los Alamos HIV Immunolog y Database Room: Macdonald EF Bring your own laptop if you have one Click here for more information
Wednesday, March 27 \| 1:00PM - 10:00PM Poster Viewing Room: Frontenac/Empress
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 1 of 10 * Alejandro Balazs, Massachusetts General Hospital, USA
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 2 of 10 * Linqi Zhang, Tsinghua University, China
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 3 of 10 Jacqueline Marlene Brady, Harvard Medical School, USA Isotype-Dependent Protection Against Mucosal HIV Transmission in Humanized Mouse Models
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 4 of 10 Samantha Marie Townsley, Walter Reed Army Institute of Research, USA Autoreactivity Mediated by Total IgG Is not Associated with the Development of Neutralization Breadth
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 5 of 10 Michael B. Zwick, The Scripps Research Institute, USA An MPER Antibody that Neutralizes HIV Using Recognition Properties and Germline Genes Shared Among Donors
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 6 of 10 Rory Henderson, Duke University, USA Antibody Fab Elbow Mutations Modulate Interdomain Flexibility and Dynamics of HIV-1 Broadly Neutralizing Antibodies
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 7 of 10 Ronnie M. Russell, University of Pennsylvania, USA Antigenic Conservation of the V2 Apex Among Primate Lentiviruses
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 8 of 10 Marie Pancera, Fred Hutchinson Cancer Research Center, USA Structural Basis for Potent Tier 2 Autologous Neutralization Elicited by Vaccination
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 9 of 10 Andres Finzi, CRCHUM, Université de Montréal, Canada An Asymmetric Opening of HIV-1 Env Is Required for Anti-Cluster A Antibody Binding
Wednesday, March 27 \| 2:30PM - 4:30PM Workshop 2: Understanding Antibody and Envelope Structures Room: Macdonald AB Speaker 10 of 10 Kimmo Rantalainen, The Scripps Research Institute, USA Electron Microscopic Characterization of HIV Envelope in Detergent Micelles, Lipid Bicelles and Nanodiscs
Wednesday, March 27 \| 4:30PM - 5:00PM Coffee Available Room: Macdonald Foyer
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 1 of 7 * Barbara L. Shacklett, University of California, Davis, USA
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 2 of 7 * Diane L. Bolton, US Military HIV Research Program, WRAIR, USA
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 3 of 7 Christian Brander, Institut de Recerca de la Sida, IrsiCaixa, Spain Vaccine-Elicited T Cells in Clinical Trials
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 4 of 7 Stephen A. Migueles, NIAID, National Institutes of Health, USA Short Talk: Ad5/HIV Vaccines Induce CD8+ T Cells with Insufficient Avidity to Kill HIV-Infected CD4+ T Cells
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 5 of 7 David B. Masopust, University of Minnesota, USA Tissue-Resident T Cells
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 6 of 7 Jonah B. Sacha, Oregon Health & Science University, USA Unconventional T Cells: Potential for Induction by Vaccination
Wednesday, March 27 \| 5:00PM - 7:00PM T Cells in HIV Vaccination and Acute Infection Room: Macdonald AB Speaker 7 of 7 Leticia Kuri-Cervantes, University of Pennsylvania, USA Short Talk: Longitudinal Dynamics of Follicular CD4+ T Cells in Acute SIV Infection
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 1 of 7 * Ramesh K. Akkina, Colorado State University, USA
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 2 of 7 * Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 3 of 7 Romas Geleziunas, Gilead Sciences, Inc., USA Attacking Latent Reservoirs
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 4 of 7 Priti Kumar, Yale School of Medicine, USA Direct in vivo Gene Engineering of Human T Cells for HIV Therapy
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 5 of 7 Susana T. Valente, Scripps Florida, USA Silencing the HIV Reservoir
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 6 of 7 Chantelle L. Ahlenstiel, Kirby Institute, University of New South Wales, Australia Short Talk: RNA-Directed Epigenetic Silencing Protects Humanized Mice during HIV Challenge
Wednesday, March 27 \| 5:00PM - 7:00PM Experimental Molecular Approaches to Targeting Viral Reservo irs This session is from HIV Cures Room: Macdonald CD Speaker 7 of 7 Fabio Romerio, University of Maryland School of Medicine, USA Short Talk: The HIV-1 Antisense Transcript Ast Induces Viral Latency via Several Silencing Pathways
Wednesday, March 27 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Frontenac/Empress No registration fees are used to fund alcohol served at this function.
Wednesday, March 27 \| 7:30PM - 10:00PM Poster Session 3 Room: Frontenac/Empress
Thursday, March 28 \| 7:00AM - 8:00AM Breakfast Room: Frontenac/Empress
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 1 of 10 * James Mark Binley, San Diego Biomedical Research Institute, USA
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 2 of 10 * Ralf Wagner, Universität Regensburg, Germany
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 3 of 10 Richard T. Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute, USA NFL Trimers: Down the Rabbit Hole and Other Unlikely Events
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 4 of 10 David Peterhoff, University Regensburg, Germany Short Talk: Stabilized HIV-1 Clade C Envelope Trimers with Increased Stability and Preferential Antigenic Properties in vitro and in vivo
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 5 of 10 Tongqing Zhou, NIAID, National Institutes of Health, USA Native Glycan Shield Is Important for Inducing Immune Responses that Neutralize Diverse Tier-2 Viruses in Sequential HIV-1 Env Trimer Immunization
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Coffee Break
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 7 of 10 Andrew J. Borst, University of Washington, USA Short Talk: Germline VRC01 Antibody Recognition of a Modified Clade C HIV-1 Envelope Trimer and a Glycosylated HIV-1 gp120 Core
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 8 of 10 Karin Loré, Karolinska Institutet, Sweden In vivo Fate of Env and Early Responses upon Immunization
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 9 of 10 Derek T. O'Hagan, GlaxoSmithKline Vaccines, USA Designing and Building the Next Generation of Vaccine Adjuvants
Thursday, March 28 \| 8:00AM - 11:15AM Env Immunogen Design and Evaluation Room: Macdonald AB Speaker 10 of 10 Aleksandar Antanasijevic, The Scripps Research Institute, USA Short Talk: Development of Self-Assembling Nanoparticle Systems for Presentation of HIV Env Trimers
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 1 of 10 * Zabrina L. Brumme, Simon Fraser University, Canada
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 2 of 10 * Eric M. Verdin, Buck Institute for Research on Aging, USA
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 3 of 10 David M. Margolis, University of North Carolina at Chapel Hill, USA Progress Towards Targeting and Eradication of HIV in Models and Man
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 4 of 10 Sharon R. Lewin, University of Melbourne, Australia Understanding Natural Variation in HIV Transcription on Antiretroviral Therapy: New Approaches to Reverse HIV Latency
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Coffee Break
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 6 of 10 Deborah Persaud, Johns Hopkins University School of Medicine, USA Latency and HIV in Pediatric Populations
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 7 of 10 Lucy Dorrell, University of Oxford, UK Novel Engineered Immune-Mobilizing T Cell Receptors-Based Drugs (‘ImmTAVs’) to Clear HIV Infection
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 8 of 10 Bojana Lucic, Universität Heidelberg, Germany Short Talk: 3D Genome Conformation is the Major Determinant of HIV-1 Integrational Hot-Spots
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 9 of 10 Alberto Bosque, George Washington University, USA Short Talk: In vitro, ex vivo and in vivo Analysis of Benzotriazine Derivatives as Latency-Reversing Agents
Thursday, March 28 \| 8:00AM - 11:15AM Targeting and Eradication of HIV This session is from HIV Cures Room: Macdonald CD Speaker 10 of 10 Marion Pardons, Université de Montréal, CRCHUM, Canada Short Talk: Latency Reversing Agents Induce Differential Responses in Distinct Memory CD4+ T Cell Subsets
Thursday, March 28 \| 11:15AM - 5:00PM On Own for Lunch
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 1 of 10 * Susana T. Valente, Scripps Florida, USA
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 2 of 10 * Tristan Alexander Scott, City of Hope, USA
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 3 of 10 Ya-Chi Ho, Yale School of Medicine, USA Filgotinib, a Janus Kinase Inhibitor, Suppresses HIV-1 Expression and T Cell Activation
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 4 of 10 Haitao Hu, University of Texas Medical Branch, USA A Novel Small Molecule Modulating BRD4 to Epigenetically Suppress HIV
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 5 of 10 Seohyun Ahn, ST Pharm. Co., Ltd., South Korea A Highly Potent and Safe Allosteric HIV-1 Integrase Inhibitor: Virological, Molecular and Preclinical Characterization of STP0404
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 6 of 10 Konstantinos Georgiou, University of California, San Francisco, USA Single-Cell Sequencing Reveals Transcriptome and Surfaceome Signatures of HIV Latently-Infected Cells
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 7 of 10 Vera Klemm, Kirby Institute, Australia Nanoparticle Delivery of Epigenetic Silencing siRNA to the Nucleus of HIV-1-Infected Cells
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 8 of 10 George B. Kyei, University of Ghana, Ghana Splicing Factor 3B Subunit 1 Interacts HIV Tat and Can Be Targeted to Prevent Viral Transcription and Reactivation from Latency
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 9 of 10 Ulf Dittmer, University of Duisburg-Essen, Germany HIV Cure Strategies with Interferon Alpha Subtype 14 in HIV-1 Infected Humanized Mice
Thursday, March 28 \| 2:30PM - 4:30PM Workshop 2: LRA and New Antiviral Strategies This session is from HIV Cures Room: Macdonald CD Speaker 10 of 10 Miriam Rosas-Umbert, AIDS Research Institute Irsicaixa – HIVACAT, Spain In vivo Effects of Romidepsin in the Bcn02 Kick&Kill Trial for HIV Remission
Thursday, March 28 \| 4:30PM - 5:00PM Coffee Available Room: Macdonald Foyer
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 1 of 6 * Devin Sok, International AIDS Vaccine Initiative, USA
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 2 of 6 * Silvija I. Staprans, Bill & Melinda Gates Foundation, USA
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 3 of 6 Mark Connors, NIAID, National Institutes of Health, USA Impact of Immunogen Design and Replication on Pre-Clinical and Clinical Immunogenicity
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 4 of 6 Peter D. Kwong, NIAID, National Institutes of Health, USA Short Talk: Steps Toward a Fusion Peptide-Based Vaccine
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 5 of 6 Hanneke Schuitemaker, Janssen Vaccines & Prevention B.V., Netherlands Advancing an HIV Vaccine Candidate through the Development Pipeline: A View from Industry
Thursday, March 28 \| 5:00PM - 6:45PM From the Lab to the Clinic: A Reality Check for Investigator s Room: Macdonald AB Speaker 6 of 6 Antu K. Dey, International AIDS Vaccine Initiative, USA Translation of Multiple Products from Discovery to the Clinic: The View from a Product Development Center at a Non-Profit Organization
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 1 of 6 * Warner Craig Greene, Gladstone Institute of Virology and Immunology, USA
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 2 of 6 * Betty Poon, NIAID, National Institutes of Health, USA
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 3 of 6 Paula M. Cannon, University of Southern California, Keck School of Medicine, USA Genome Engineering Strategies to Generate HIV-Resistant Cells
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 4 of 6 Scott G. Kitchen, University of California, Los Angeles AIDS Institute, USA Engineering Long-Term HIV-Specific Immunity through Chimeric Antigen Receptors and Stem Cells
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 5 of 6 Kevin V. Morris, Center for Gene Therapy, City of Hope, USA Flare, Excise, Kill: Means to a Functional Cure for HIV
Thursday, March 28 \| 5:00PM - 6:45PM Protect and Kill Strategies to a Functional Cure This session is from HIV Cures Room: Macdonald CD Speaker 6 of 6 Chris Peterson, Fred Hutchinson Cancer Research Center, USA Short Talk: Trafficking of Stem Cell-Derived CAR T-Cells to B-Cell Follicles in SHIV-Infected Nonhuman Primates
Thursday, March 28 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Room: Macdonald AB
Thursday, March 28 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) This session is from HIV Cures Room: Macdonald CD
Thursday, March 28 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Frontenac/Empress No registration fees are used to fund alcohol served at this function.
Thursday, March 28 \| 8:00PM - 11:00PM Entertainment Room: Frontenac/Empress Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Thursday, March 28 \| 8:00PM - 11:00PM Cash Bar Room: Frontenac/Empress
Friday, March 29 \| 10:24AM - 10:24AM Departure *Session Chair.